Dermatology clinical trials recruiting in Illinois

30 recruiting dermatology trials match in Illinois. Showing 20.

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Skokie, Illinois

• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)Recruiting

  Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID) · Chicago, Illinois

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Birmingham, Alabama

• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 3 · Nektar Therapeutics · Normal, Illinois

• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Inmagene LLC · Rolling Meadows, Illinois

• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruiting

  Phase 1 · UCB Biopharma SRL · Chicago, Illinois

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Glendale, Arizona

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Rolling Meadows, Illinois

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Chicago, Illinois

• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 · Incyte Corporation · Skokie, Illinois

• An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Rolling Meadows, Illinois

• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Recruiting

  Phase 4 · Eli Lilly and Company · Chicago, Illinois

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesRecruiting

  Phase 3 · Takeda · Mesa, Arizona

• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & AdultsRecruiting

  N/A · Galderma R&D · Chicago, Illinois

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesRecruiting

  Phase 3 · Takeda · Orland Park, Illinois

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting

  Phase 3 · Takeda · Rolling Meadows, Illinois

• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisRecruiting

  Phase 2 · UCB Biopharma SRL · Chicago, Illinois

• The Gut and Skin Microbiome in Vitiligo Disease ProgressionRecruiting

  N/A · Northwestern University · Chicago, Illinois

• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic TreatmentRecruiting

  N/A · Sanofi · Normal, Illinois

• Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruiting

  N/A · Duke University · Chicago, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.